BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 3037892)

  • 1. Atrial natriuretic peptide and the kidney.
    Ballermann BJ; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):7-12. PubMed ID: 3037892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
    Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
    Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
    J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic hormones: comparison of renal effects.
    Bourgoignie JJ
    Klin Wochenschr; 1987; 65 Suppl 8():14-20. PubMed ID: 2955162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney.
    Marin-Grez M; Fleming JT; Steinhausen M
    Nature; 1986 Dec 4-10; 324(6096):473-6. PubMed ID: 2946962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
    Beutler JJ; Koomans HA; Bijlsma JA; Dorhout Mees EJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1314-9. PubMed ID: 2148189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of saline-induced natriuresis upon exposure of the kidney to the physical effects of extracellular fluid volume expansion.
    Fitzgibbons JP; Gennari FJ; Garfinkel HB; Cortell S
    J Clin Invest; 1974 Dec; 54(6):1428-36. PubMed ID: 4436441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible physiological role of atrial natriuretic peptide in body fluid volume regulation.
    Hirata Y; Ishii M; Fukui K; Hayakawa H; Namba S; Dan Y; Ishimitsu T; Sugimoto T; Kimura K; Matsuoka H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S63-8. PubMed ID: 2473354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstraton of a role of physical factors as determinants of the natriuretic response to volume expansion.
    Martino JA; Earley LE
    J Clin Invest; 1967 Dec; 46(12):1963-78. PubMed ID: 6074001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption.
    Harris PJ; Thomas D; Morgan TO
    Nature; 1987 Apr 16-22; 326(6114):697-8. PubMed ID: 2951600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of atrial natriuretic peptide on sodium homeostasis in experimental renal failure.
    Nitta K; Naruse M; Sanaka T; Tsuchiya K; Sugino N
    Jpn J Exp Med; 1989 Oct; 59(5):181-8. PubMed ID: 2533287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
    Loutzenhiser R; Hayashi K; Epstein M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):522-8. PubMed ID: 2969977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in the isolated perfused rat kidney.
    Brier ME; Brier RA; Luft FC; Aronoff GR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):868-73. PubMed ID: 2961879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K; Heidbreder E; Hummel S; Heidland A
    Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of angiotensin II in the renal response to atrial natriuretic peptide in normal subjects.
    Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y
    J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S55-8. PubMed ID: 2473352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of atrial natriuretic peptides.
    Schnermann J; Briggs JP
    Klin Wochenschr; 1987; 65 Suppl 8():92-6. PubMed ID: 2955165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between plasma atrial natriuretic peptide (ANP) and glomerular ANP receptors in 5/6 nephrectomized rats.
    Jin H; Yuan ZY; Du XH; Su G; Zhang L; Wang MX; Dong Y; Liu DX; Zou WZ; Wang SL
    Chin Med J (Engl); 1990 Oct; 103(10):794-9. PubMed ID: 2176581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.